U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883630) titled 'A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC' on March 05.

Brief Summary: This study will evaluate the efficacy, safety, pharmacokinetics and immunogenicity of RC148 injection as a single agent or in combination for the treatment of locally advanced or metastatic non-small cell lung cancer

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: DRUG: RC148 plus Carboplatin and Paclitaxel/pemetrexed

RC148; Carboplatin; Paclitaxel; pemetrexed

DRUG: RC148

RC148 Monotherapy

Recruitment Status: NOT_YET_RECRUITING

Sponsor: RemeG...